Novartis AG (Novartis AG) Total Tax Payable : $1,650 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Total Tax Payable?

Novartis AG's Total Tax Payable for the quarter that ended in Mar. 2024 was $1,650 Mil.

Novartis AG's quarterly Total Tax Payable increased from Sep. 2023 ($2,129 Mil) to Dec. 2023 ($2,409 Mil) but then declined from Dec. 2023 ($2,409 Mil) to Mar. 2024 ($1,650 Mil).

Novartis AG's annual Total Tax Payable increased from Dec. 2021 ($3,034 Mil) to Dec. 2022 ($3,369 Mil) but then declined from Dec. 2022 ($3,369 Mil) to Dec. 2023 ($2,409 Mil).

Novartis AG Total Tax Payable Historical Data

The historical data trend for Novartis AG's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Total Tax Payable Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

2,665.00

3,207.00

3,034.00

3,369.00

2,409.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial															2,966.00	2,651.00	2,129.00	2,409.00	1,650.00

Novartis AG Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Novartis AG Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Novartis AG's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.